Northern Trust’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Northern Trust’s Portfolio TMBR Stock Details TMBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,438	Closed	-$15K	–	4759
2022 Q3	$15K	Hold	2,438	–	–	﹤0.01%	4599
2022 Q2	$38K	Buy	2,438 +1,233	+102%	+$18K	﹤0.01%	4483
2022 Q1	$23K	Hold	1,205	–	–	﹤0.01%	4658
2021 Q4	$23K	Hold	1,205	–	–	﹤0.01%	4702
2021 Q3	$55K	Hold	1,205	–	–	﹤0.01%	4522
2021 Q2	$73K	Buy	+1,205	New	+$84.7K	﹤0.01%	4423
2020 Q2	–	Sell	-37	Closed	-$7K	–	4322
2020 Q1	$7K	Buy	+37	New	+$9.44K	﹤0.01%	4175
2019 Q2	–	Sell	-6	Closed	-$8K	–	4306
2019 Q1	$8K	Hold	6	–	–	﹤0.01%	4187
2018 Q4	$10K	Hold	6	–	–	﹤0.01%	4201
2018 Q3	$18K	Hold	6	–	–	﹤0.01%	4226
2018 Q2	$20K	Hold	6	–	–	﹤0.01%	4216
2018 Q1	$21K	Hold	6	–	–	﹤0.01%	4165
2017 Q4	$10K	Hold	6	–	–	﹤0.01%	4196
2017 Q3	$26K	Hold	6	–	–	﹤0.01%	4130
2017 Q2	$44K	Hold	6	–	–	﹤0.01%	4095
2017 Q1	$47K	Buy	+6	New	+$41.5K	﹤0.01%	4059

Other funds holding TMBR

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

CPG

Cornerstone Planning Group Fairfield, New Jersey $749M AUM 17.97% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Northern Trust's TMBR Position: Q4 2022 in Review

Northern Trust sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2022, closing a stake of 2,438 shares — an estimated $15K sold.

Northern Trust first reported a position in TMBR in Q1 2017 and held it in 16 quarters. The position peaked at $73K in Q2 2021. 11 funds tracked by Wall St. Rank hold TMBR as of Q4 2022.

Northern Trust reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Northern Trust sold 2,438 Timber Pharmaceuticals, Inc. shares in Q4 2022, an estimated $15K.
Northern Trust first reported a position in Timber Pharmaceuticals, Inc. in Q1 2017 and held it in 16 quarters.
Northern Trust's Timber Pharmaceuticals, Inc. position peaked at $73K in Q2 2021.
11 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2022.

Based on Northern Trust's 13F filing for Q4 2022, filed 13 Feb 2023.